Related references
Note: Only part of the references are listed.New drugs for non-alcoholic steatohepatitis
Ana-Carolina Cardoso et al.
LIVER INTERNATIONAL (2020)
Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States
Michael H. Le et al.
PLOS ONE (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Effect of two andrographolide derivatives on cellular and rodent models of non-alcoholic fatty liver disease
Erenius Toppo et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Non-alcoholic fatty liver disease: An expanded review
Mark Benedict et al.
WORLD JOURNAL OF HEPATOLOGY (2017)
PPARs and nonalcoholic fatty liver disease
Kim H. H. Liss et al.
BIOCHIMIE (2017)
Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells
Lu Zeng et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Differential Lipotoxic Effects of Palmitate and Oleate in Activated Human Hepatic Stellate Cells and Epithelial Hepatoma Cells
Alexandra M. Hetherington et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Bavachinin, as a novel natural pan-PPAR agonist, exhibits unique synergistic effects with synthetic PPAR-γ and PPAR-α agonists on carbohydrate and lipid metabolism in db/db and diet-induced obese mice
Li Feng et al.
DIABETOLOGIA (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Data Warrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis
Thomas Sander et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Design, Synthesis, and Biological Evaluation of Andrographolide Derivatives as Potent Hepatoprotective Agents
Chunlei Tang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2014)
Andrographolide: progression in its modifications and applications - a patent review (2012-2014)
Chantana Aromdee
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
Review on Liver Inflammation and Antiinflammatory Activity of Andrographis paniculata for Hepatoprotection
Lee Suan Chua
PHYTOTHERAPY RESEARCH (2014)
Therapeutic Role of Ursolic Acid on Ameliorating Hepatic Steatosis and Improving Metabolic Disorders in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Rats
Songtao Li et al.
PLOS ONE (2014)
Peroxisome Proliferator-Activated Receptor α Activation Induces Hepatic Steatosis, Suggesting an Adverse Effect
Fang Yan et al.
PLOS ONE (2014)
GPBAR1/TGR5 Mediates Bile Acid-Induced Cytokine Expression in Murine Kupffer Cells
Guiyu Lou et al.
PLOS ONE (2014)
Experimental models of non-alcoholic fatty liver disease in rats
Otto Kucera et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Andrographolide Prevents High-Fat Diet-Induced Obesity in C57BL/6 Mice by Suppressing the Sterol Regulatory Element-Binding Protein Pathway
Lili Ding et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Synthesis of new andrographolide derivatives and evaluation of their antidyslipidemic, LDL-oxidation and antioxidant activity
Sukanya Pandeti et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Synthesis and Preliminary Antihyperlipidaemic Activities Evaluation of Andrographolide Derivatives
Bin Wang et al.
MEDICINAL CHEMISTRY (2012)
Regulation effects on abnormal glucose and lipid metabolism of TZQ-F, a new kind of Traditional Chinese Medicine
Wang Tao et al.
JOURNAL OF ETHNOPHARMACOLOGY (2010)
Oleanolic Acid is a Selective Farnesoid X Receptor Modulator
Wenming Liu et al.
PHYTOTHERAPY RESEARCH (2010)
Drawing the PDB: Protein-Ligand Complexes in Two Dimensions
Katrin Stierand et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment
Zaijun Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Synthesis of andrographolide derivatives and their TNF-α and IL-6 expression inhibitory activities
Jing Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
The Interleukin-1 receptor antagonist is a direct target gene of PPARα in liver
Rinke Stienstra et al.
JOURNAL OF HEPATOLOGY (2007)
A semiempirical free energy force field with charge-based desolvation
Ruth Huey et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2007)
A model of insulin resistance and nonalcoholic steatohepatitis in rats -: Role of peroxisome proliferator-activated receptor-α and n-3 polyunsaturated fatty acid treatment on liver injury
Gianluca Svegliati-Baroni et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues
Joe Dundas et al.
NUCLEIC ACIDS RESEARCH (2006)
PRODRG:: a tool for high-throughput crystallography of protein-ligand complexes
AW Schüttelkopf et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
H Sato et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
